Retaglutide is a innovative GLP-1 receptor agonist currently under investigation for the management of obesity. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://mariyahcbqw594657.snack-blog.com/39143851/trelaglutide-exploring-a-new-option-for-chronic-diseases